— Launching a collaboration to advance foundational research in cancer- and aging-related fields with a view toward future translation and societal implementation —
Bloom X³ (the “Company”) announces that it has entered into a joint research agreement with the National Center for Geriatrics and Gerontology (National Center for Geriatrics and Gerontology: NCGG; “NCGG”) and Dr. Masahiro Sugimoto, Director of the Cellular Pathophysiology Research Department, and has initiated the joint research collaboration in cancer- and aging-related fields.
Through this joint research, the Company will generate and deepen scientific insights in foundational science related to aging and age-associated biology, and will explore their potential applications in medicine and healthcare. By working with leading academic expertise, Bloom X³ will further strengthen the bridge from evidence-based research and development to societal implementation.
Overview of the Joint Research
- Partner: The National Center for Geriatrics and Gerontology (NCGG)
- Joint Research Counterpart: Dr. Masahiro Sugimoto, Director, Cellular Pathophysiology Research Department
- Agreement Type: Joint Research Agreement
- Research Area: Cancer-, aging-, and age-related fields
- Purpose: Advancing foundational science and examining potential applications in medicine and healthcare
- Disclosure Policy: Details such as research themes, methodologies, and deliverables will be disclosed, as appropriate, in accordance with contractual arrangements and research progress.
Hiro Kimura, Ph.D., R.Ph.
Founder＆CEO / Research Lead, Bloom X³
“Through our joint research with NCGG, we will carefully deepen foundational science in cancer- and aging-related fields and work to build robust evidence that can contribute to medicine and healthcare.”
About the National Center for Geriatrics and Gerontology (NCGG)
The National Center for Geriatrics and Gerontology (NCGG), which is composed of the National Hospital for Geriatric Medicine and the Research Institute, is one of the six national centers for advanced and specialized medicine in Japan.
Our mission is to dedicate ourselves to promotion of the physical and mental health of the elderly, so that they can achieve a life-long independence, and the improvement of the health and welfare for the people and the society.
With the close cooperation and interaction between the hospital and the research institute, NCGG as a whole keeps on making efforts toward the realization of healthy and longevity society.
About Bloom X³
Bloom X³ advances initiatives that connect research and commercialization, with a focus on life sciences (including cancer, aging, rejuvenation, regenerative medicine, and innovative drug discovery technology platforms). Leveraging domestic and global networks and expertise, Bloom X³ is committed to creating value grounded in scientific evidence.
